Mar 31, 2020 - BMY vs. AZN: Which Stock Is the Better Value Option?
Mar 31, 2020 - Top Ranked Income Stocks to Buy for March 31st
Mar 30, 2020 - AVEO ceases the phase II CyFi-2 study on ficlatuzumab plus high-dose cytarabine for treating patients with relapsed/refractory acute myeloid leukemia to combat the COVID-19 outbreak.
Mar 30, 2020 - Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Bristol-Myers Squibb (BMY) have what it takes? Let's find out.
Mar 30, 2020 - AstraZeneca's (AZN) Imfinzi gets FDA approval as first-line treatment for extensive-stage small cell lung cancer patients. A phase III study on Farxiga in CKD patients meets endpoint earlier than expected.
Mar 30, 2020 - Sanofi (SNY) begins treatment in a second phase II/III study evaluating its rheumatoid arthritis drug Kevzara to treat patients with severe COVID-19 outside the United States.
Mar 30, 2020 - Drug developers took center stage as the world looks to these companies to deliver an answer to COVID-19.
Mar 27, 2020 - The FDA approves Bristol Myers' (BMY) Zeposia for the treatment of adults with relapsing forms of multiple sclerosis.
Mar 27, 2020 - Bargain prices and tremendous growth prospects make these stocks really attractive.
Mar 27, 2020 - Companies in the news are: BMY, WORK, SIG, FDS